Morepen Laboratories Limited MOREPENLAB.NS · Stock Open Morepen Laboratories Limited in new tab
Morepen Laboratories Limited Analysis (MOREPENLAB.NS)
Is Morepen Laboratories Limited a good investment? Morepen Laboratories Limited (MOREPENLAB.NS) is currently trading at 133.60 INR.
In terms of valuation, the stock trades at a P/E ratio of 46.41. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Morepen Laboratories Limited is expected to release its next earnings report on May 11, 2026.
For income investors, Morepen Laboratories Limited pays a dividend yield of 0.17%. With a payout ratio of 8%, the dividend appears sustainable.
Investor FAQ
Does Morepen Laboratories Limited pay a dividend?
Yes, it pays an annual dividend of 0.20 INR (0.17% yield).
What asset class is Morepen Laboratories Limited?
Morepen Laboratories Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be May 11, 2026. The company currently has a trailing EPS of 2.56.
Company Profile
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
0.20 INR
|
| Oct. 26, 2026 | 0.2000 |
| ▸2025 |
0.20 INR
|
| Oct. 6, 2025 | 0.2000 |
| ▸2002 |
0.60 INR
|
| Oct. 8, 2002 | 0.6000 |
| ▸2001 |
0.70 INR
|
| Oct. 1, 2001 | 0.2000 |
| March 1, 2001 | 0.5000 |
| ▸2000 |
3.10 INR
|
| Oct. 1, 2000 | 0.1000 |
| April 28, 2000 | 3.0000 |
| ▸1999 |
15.00 INR
|
| June 18, 1999 | 15.0000 |
| ▸1998 |
12.50 INR
|
| Oct. 1, 1998 | 12.5000 |
| ▸1997 |
12.50 INR
|
| Oct. 1, 1997 | 12.5000 |
| ▸1996 |
11.00 INR
|
| Oct. 1, 1996 | 11.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Morepen Laboratories Limited | Oct 26, 2026 | Upcoming | 0.2 INR |
Community Discussion